Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
4.390
-0.210 (-4.57%)
May 15, 2026, 11:35 AM EDT - Market open
Precigen Market Cap
Precigen has a market cap or net worth of $1.57 billion as of May 15, 2026. Its market cap has increased by 241.20% in one year.
Market Cap
1.57B
Enterprise Value
1.68B
1-Year Change
241.20%
Ranking
Category
Stock Price
$4.39
Market Cap Chart
Since August 8, 2013, Precigen's market cap has decreased from $2.32B to $1.57B, a decrease of -32.55%. That is a compound annual growth rate of -3.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 1.64B | 10.89% |
| Dec 31, 2025 | 1.48B | 350.91% |
| Dec 31, 2024 | 328.00M | -1.68% |
| Dec 29, 2023 | 333.60M | 5.44% |
| Dec 30, 2022 | 316.40M | -58.75% |
| Dec 31, 2021 | 767.00M | -59.45% |
| Dec 31, 2020 | 1.89B | 112.19% |
| Dec 31, 2019 | 891.50M | -0.66% |
| Dec 31, 2018 | 897.40M | -35.47% |
| Dec 29, 2017 | 1.39B | -51.74% |
| Dec 30, 2016 | 2.88B | -17.89% |
| Dec 31, 2015 | 3.51B | 26.82% |
| Dec 31, 2014 | 2.77B | 19.88% |
| Dec 31, 2013 | 2.31B | -0.51% |
| Aug 8, 2013 | 2.32B | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agios Pharmaceuticals | 1.72B |
| Inhibrx Biosciences | 1.71B |
| Palvella Therapeutics | 1.71B |
| Innoviva | 1.70B |
| Vericel | 1.69B |
| Nurix Therapeutics | 1.67B |
| Recursion Pharmaceuticals | 1.66B |
| Nuvation Bio | 1.66B |